Effects of Cerebrolysin™ on neurogenesis in an APP transgenic model of Alzheimer’s disease

Author： Rockenstein Edward Mante Michael Adame Anthony Crews Leslie Moessler Herbert Masliah Eliezer

ISSN： 0001-6322

Source： Acta Neuropathologica, Vol.113, Iss.3, 2007-03, pp. : 265-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gender dependent APP processing in a transgenic mouse model of Alzheimer’s disease

By Schäfer S. Wirths O. Multhaup G. Bayer T. A.

Journal of Neural Transmission, Vol. 114, Iss. 3, 2007-03 ,pp. : 387-394

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer’s Disease After Implantation of VEGF-loaded PLGA Nanospheres

Current Alzheimer Research, Vol. 12, Iss. 10, 2015-12 ,pp. : 932-9

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Prolyl Endopeptidase Expression in Aging, APP Transgenic Mice and Alzheimer’s Disease

By Roßner Steffen Schulz Ingo Zeitschel Ulrike Schliebs Reinhard Bigl Volker Demuth Hans-Ulrich

Neurochemical Research, Vol. 30, Iss. 6-7, 2005-06 ,pp. : 695-702

Springer Publishing Company

Access to resources Recommend Favorite

Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer’s disease

By Wei Z.-H. He Q.-B. Wang H. Su B.-H. Chen H.-Z.

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 629-634

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer’s Disease

Current Alzheimer Research, Vol. 10, Iss. 5, 2013-01 ,pp. : 494-506

Bentham Science Publishers

Access to resources Recommend Favorite